Literature DB >> 16567922

Childhood primary mesenteric seminoma.

Sameer Bakhshi1, Devinder Singh, A K Karak, Sanjay Thulkar.   

Abstract

We report an 11-year-old child who presented with an abdominal lump and was diagnosed as having an extragonal primary mesenteric seminoma. Patient was treated with 4 cycles of combination chemotherapy cisplatin, etoposide and bleomycin; he is now disease free for 2 years. We discuss and review extragonadal germ cell tumors arising from the mesentery and their management.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16567922     DOI： 10.1007/bf02825492

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  7 in total

1.  [Mesenteric seminoma: apropos of a case].

Authors:  A Dubois; C Janbon; H Lapeyrie; C Marty-Double
Journal:  Gastroenterol Clin Biol       Date:  1986-05

Review 2.  Growth factors and testicular development.

Authors:  D J Lamb
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

3.  Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.

Authors:  C Bokemeyer; J P Droz; A Horwich; A Gerl; S D Fossa; J Beyer; J Pont; H J Schmoll; L Kanz; L Einhorn; C R Nichols; J T Hartmann
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

4.  Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.

Authors:  Yu-Juei Hsu; Lu Pai; Yeu-Chin Chen; Ching-Liang Ho; Woei-Yau Kao; Tsu-Yi Chao
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

5.  Changes in protooncogene expression correlated with general and sex-specific differentiation in murine primordial germ cells.

Authors:  E C Coucouvanis; P P Jones
Journal:  Mech Dev       Date:  1993-07       Impact factor: 1.882

6.  Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.

Authors:  Barbara Cushing; Roger Giller; John W Cullen; Neyssa M Marina; Stephen J Lauer; Thomas A Olson; Paul C Rogers; Paul Colombani; Frederick Rescorla; Deborah F Billmire; Charles D Vinocur; Edith P Hawkins; Mary Margaret Davis; Elizabeth J Perlman; Wendy B London; Robert P Castleberry
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

7.  Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.

Authors:  T Strohmeyer; D Reese; M Press; R Ackermann; M Hartmann; D Slamon
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.